Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-14

FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (Bostal LLC)

View source ↗

Summary

FDA approved a supplemental application for solifenacin succinate submitted by Bostal LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solifenacin succinate (solifenacin)

Snippet

SUPPL AP for SOLIFENACIN SUCCINATE (SOLIFENACIN SUCCIATE)